asa guidelines for glp-1 drugs New therapeutic agents type 2 diabetes: anaesthetic considerations. A narrative review Perioperative anesthesia management of GLP-1

Stopping your treatment could mean losing the progress you've made and having to restart from the beginning

The 2025 Frontiers in Aging clinical review (Frontiers in Aging 2025) summarises the documented short-term adverse effects in adult populations: peripheral oedema and fluid retention are common at initiation, carpal tunnel syndrome occurs in a meaningful proportion of users, hyperglycaemia and insulin resistance can emerge because GH is physiologically counter-regulatory to insulin, and gynaecomastia has been reported, particularly at higher doses

Enjoy 1 tablespoon daily, ideally on an empty stomach.

& Ycel, D

A red flag: a COA from a third-party lab you cannot independently verify via the lab's own website or accreditation database

Melatonin has anti-oxidant properties against ROS in H